Why the study?
To provide an overview of the current status of cardiovascular modelling and outline the processes and challenges required for wider exploitation in personal health management and clinical practice.
This position paper outlines the current status, challenges, and future directions of cardiovascular modeling and digital twins for personalized medicine and clinical decision support.
Demands systematic physics-AI-data integration for digital twins now; extends guidelines toward personalized cardiovascular decision support.
The aim of this position paper is to provide a brief overview of the current status of cardiovascular modelling and of the processes required and some of the challenges to be addressed to see wider exploitation in both personal health management and clinical practice. In most branches of engineering the concept of the digital twin, informed by extensive and continuous monitoring and coupled with robust data assimilation and simulation techniques, is gaining traction: the Gartner Group listed it as one of the top ten digital trends in 2018. The cardiovascular modelling community is starting to develop a much more systematic approach to the combination of physics, mathematics, control theory, artificial intelligence, machine learning, computer science and advanced engineering methodology, as well as working more closely with the clinical community to better understand and exploit physiological measurements, and indeed to develop jointly better measurement protocols informed by model-based understanding. Developments in physiological modelling, model personalisation, model outcome uncertainty, and the role of models in clinical decision support are addressed and 'where-next' steps and challenges discussed.
No takes yet. Share an insight, caveat, or question.
Hose et al. (2019) conducted a review in Cardiovascular disease. Cardiovascular modelling (Digital twin) was evaluated. Cardiovascular modelling and digital twin concepts require a systematic integration of physics, AI, and clinical data to advance personalized medicine and clinical decision support.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: